Global Osteoarthritis Drugs Market Growth 2025-2031

December 2025 | 103 pages | ID: GACD1A27A49EN
LP Information

Abstracts

The global Osteoarthritis Drugs market size is predicted to grow from US$ 9974 million in 2025 to US$ 12280 million in 2031; it is expected to grow at a CAGR of 3.5% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis.

North America is the largest Drugs for Osteoarthritis Pain market with about 36% market share. Europe is follower, accounting for about 27% market share.

The key players are Pfizer, Johnson & Johnson, GlaxoSmithKline, Bayer, Eli Lilly, Novartis, Sanofi, Horizon Pharma, Abbott, Mylan, Daiichi Sankyo, TEVA, Almatica Pharma, Astellas Pharma, Tide Pharmaceutical, Iroko Pharmaceuticals, Hengrui Pharmaceutical, Abiogen Pharma etc. Top 5 companies occupied about 66% market share.

LP Information, Inc. (LPI) ' newest research report, the “Osteoarthritis Drugs Industry Forecast” looks at past sales and reviews total world Osteoarthritis Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Osteoarthritis Drugs sales for 2025 through 2031. With Osteoarthritis Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Osteoarthritis Drugs industry.

This Insight Report provides a comprehensive analysis of the global Osteoarthritis Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Osteoarthritis Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Osteoarthritis Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Osteoarthritis Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Osteoarthritis Drugs.

This report presents a comprehensive overview, market shares, and growth opportunities of Osteoarthritis Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Oral
• Injection
• External

Segmentation by Application:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Johnson & Johnson
• Pfizer
• Eli Lilly
• Abbott
• GlaxoSmithKline
• Sanofi
• Flexion Therapeutics

Key Questions Addressed in this Report

What is the 10-year outlook for the global Osteoarthritis Drugs market?

What factors are driving Osteoarthritis Drugs market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Osteoarthritis Drugs market opportunities vary by end market size?

How does Osteoarthritis Drugs break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Osteoarthritis Drugs Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Osteoarthritis Drugs by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Osteoarthritis Drugs by Country/Region, 2020, 2024 & 2031
2.2 Osteoarthritis Drugs Segment by Type
  2.2.1 Oral
  2.2.2 Injection
  2.2.3 External
2.3 Osteoarthritis Drugs Sales by Type
  2.3.1 Global Osteoarthritis Drugs Sales Market Share by Type (2020-2025)
  2.3.2 Global Osteoarthritis Drugs Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Osteoarthritis Drugs Sale Price by Type (2020-2025)
2.4 Osteoarthritis Drugs Segment by Application
  2.4.1 Hospital Pharmacies
  2.4.2 Retail Pharmacies
  2.4.3 Online Pharmacies
2.5 Osteoarthritis Drugs Sales by Application
  2.5.1 Global Osteoarthritis Drugs Sale Market Share by Application (2020-2025)
  2.5.2 Global Osteoarthritis Drugs Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Osteoarthritis Drugs Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Osteoarthritis Drugs Breakdown Data by Company
  3.1.1 Global Osteoarthritis Drugs Annual Sales by Company (2020-2025)
  3.1.2 Global Osteoarthritis Drugs Sales Market Share by Company (2020-2025)
3.2 Global Osteoarthritis Drugs Annual Revenue by Company (2020-2025)
  3.2.1 Global Osteoarthritis Drugs Revenue by Company (2020-2025)
  3.2.2 Global Osteoarthritis Drugs Revenue Market Share by Company (2020-2025)
3.3 Global Osteoarthritis Drugs Sale Price by Company
3.4 Key Manufacturers Osteoarthritis Drugs Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Osteoarthritis Drugs Product Location Distribution
  3.4.2 Players Osteoarthritis Drugs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR OSTEOARTHRITIS DRUGS BY GEOGRAPHIC REGION

4.1 World Historic Osteoarthritis Drugs Market Size by Geographic Region (2020-2025)
  4.1.1 Global Osteoarthritis Drugs Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Osteoarthritis Drugs Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Osteoarthritis Drugs Market Size by Country/Region (2020-2025)
  4.2.1 Global Osteoarthritis Drugs Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Osteoarthritis Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Osteoarthritis Drugs Sales Growth
4.4 APAC Osteoarthritis Drugs Sales Growth
4.5 Europe Osteoarthritis Drugs Sales Growth
4.6 Middle East & Africa Osteoarthritis Drugs Sales Growth

5 AMERICAS

5.1 Americas Osteoarthritis Drugs Sales by Country
  5.1.1 Americas Osteoarthritis Drugs Sales by Country (2020-2025)
  5.1.2 Americas Osteoarthritis Drugs Revenue by Country (2020-2025)
5.2 Americas Osteoarthritis Drugs Sales by Type (2020-2025)
5.3 Americas Osteoarthritis Drugs Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Osteoarthritis Drugs Sales by Region
  6.1.1 APAC Osteoarthritis Drugs Sales by Region (2020-2025)
  6.1.2 APAC Osteoarthritis Drugs Revenue by Region (2020-2025)
6.2 APAC Osteoarthritis Drugs Sales by Type (2020-2025)
6.3 APAC Osteoarthritis Drugs Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Osteoarthritis Drugs by Country
  7.1.1 Europe Osteoarthritis Drugs Sales by Country (2020-2025)
  7.1.2 Europe Osteoarthritis Drugs Revenue by Country (2020-2025)
7.2 Europe Osteoarthritis Drugs Sales by Type (2020-2025)
7.3 Europe Osteoarthritis Drugs Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Osteoarthritis Drugs by Country
  8.1.1 Middle East & Africa Osteoarthritis Drugs Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Osteoarthritis Drugs Revenue by Country (2020-2025)
8.2 Middle East & Africa Osteoarthritis Drugs Sales by Type (2020-2025)
8.3 Middle East & Africa Osteoarthritis Drugs Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Osteoarthritis Drugs
10.3 Manufacturing Process Analysis of Osteoarthritis Drugs
10.4 Industry Chain Structure of Osteoarthritis Drugs

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Osteoarthritis Drugs Distributors
11.3 Osteoarthritis Drugs Customer

12 WORLD FORECAST REVIEW FOR OSTEOARTHRITIS DRUGS BY GEOGRAPHIC REGION

12.1 Global Osteoarthritis Drugs Market Size Forecast by Region
  12.1.1 Global Osteoarthritis Drugs Forecast by Region (2026-2031)
  12.1.2 Global Osteoarthritis Drugs Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Osteoarthritis Drugs Forecast by Type (2026-2031)
12.7 Global Osteoarthritis Drugs Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Johnson & Johnson
  13.1.1 Johnson & Johnson Company Information
  13.1.2 Johnson & Johnson Osteoarthritis Drugs Product Portfolios and Specifications
  13.1.3 Johnson & Johnson Osteoarthritis Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Johnson & Johnson Main Business Overview
  13.1.5 Johnson & Johnson Latest Developments
13.2 Pfizer
  13.2.1 Pfizer Company Information
  13.2.2 Pfizer Osteoarthritis Drugs Product Portfolios and Specifications
  13.2.3 Pfizer Osteoarthritis Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Pfizer Main Business Overview
  13.2.5 Pfizer Latest Developments
13.3 Eli Lilly
  13.3.1 Eli Lilly Company Information
  13.3.2 Eli Lilly Osteoarthritis Drugs Product Portfolios and Specifications
  13.3.3 Eli Lilly Osteoarthritis Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Eli Lilly Main Business Overview
  13.3.5 Eli Lilly Latest Developments
13.4 Abbott
  13.4.1 Abbott Company Information
  13.4.2 Abbott Osteoarthritis Drugs Product Portfolios and Specifications
  13.4.3 Abbott Osteoarthritis Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Abbott Main Business Overview
  13.4.5 Abbott Latest Developments
13.5 GlaxoSmithKline
  13.5.1 GlaxoSmithKline Company Information
  13.5.2 GlaxoSmithKline Osteoarthritis Drugs Product Portfolios and Specifications
  13.5.3 GlaxoSmithKline Osteoarthritis Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 GlaxoSmithKline Main Business Overview
  13.5.5 GlaxoSmithKline Latest Developments
13.6 Sanofi
  13.6.1 Sanofi Company Information
  13.6.2 Sanofi Osteoarthritis Drugs Product Portfolios and Specifications
  13.6.3 Sanofi Osteoarthritis Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Sanofi Main Business Overview
  13.6.5 Sanofi Latest Developments
13.7 Flexion Therapeutics
  13.7.1 Flexion Therapeutics Company Information
  13.7.2 Flexion Therapeutics Osteoarthritis Drugs Product Portfolios and Specifications
  13.7.3 Flexion Therapeutics Osteoarthritis Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Flexion Therapeutics Main Business Overview
  13.7.5 Flexion Therapeutics Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Osteoarthritis Drugs Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Osteoarthritis Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Injection
Table 5. Major Players of External
Table 6. Global Osteoarthritis Drugs Sales by Type (2020-2025) & (MT)
Table 7. Global Osteoarthritis Drugs Sales Market Share by Type (2020-2025)
Table 8. Global Osteoarthritis Drugs Revenue by Type (2020-2025) & ($ million)
Table 9. Global Osteoarthritis Drugs Revenue Market Share by Type (2020-2025)
Table 10. Global Osteoarthritis Drugs Sale Price by Type (2020-2025) & (USD/Kg)
Table 11. Global Osteoarthritis Drugs Sale by Application (2020-2025) & (MT)
Table 12. Global Osteoarthritis Drugs Sale Market Share by Application (2020-2025)
Table 13. Global Osteoarthritis Drugs Revenue by Application (2020-2025) & ($ million)
Table 14. Global Osteoarthritis Drugs Revenue Market Share by Application (2020-2025)
Table 15. Global Osteoarthritis Drugs Sale Price by Application (2020-2025) & (USD/Kg)
Table 16. Global Osteoarthritis Drugs Sales by Company (2020-2025) & (MT)
Table 17. Global Osteoarthritis Drugs Sales Market Share by Company (2020-2025)
Table 18. Global Osteoarthritis Drugs Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Osteoarthritis Drugs Revenue Market Share by Company (2020-2025)
Table 20. Global Osteoarthritis Drugs Sale Price by Company (2020-2025) & (USD/Kg)
Table 21. Key Manufacturers Osteoarthritis Drugs Producing Area Distribution and Sales Area
Table 22. Players Osteoarthritis Drugs Products Offered
Table 23. Osteoarthritis Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Osteoarthritis Drugs Sales by Geographic Region (2020-2025) & (MT)
Table 27. Global Osteoarthritis Drugs Sales Market Share Geographic Region (2020-2025)
Table 28. Global Osteoarthritis Drugs Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Osteoarthritis Drugs Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Osteoarthritis Drugs Sales by Country/Region (2020-2025) & (MT)
Table 31. Global Osteoarthritis Drugs Sales Market Share by Country/Region (2020-2025)
Table 32. Global Osteoarthritis Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Osteoarthritis Drugs Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Osteoarthritis Drugs Sales by Country (2020-2025) & (MT)
Table 35. Americas Osteoarthritis Drugs Sales Market Share by Country (2020-2025)
Table 36. Americas Osteoarthritis Drugs Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Osteoarthritis Drugs Sales by Type (2020-2025) & (MT)
Table 38. Americas Osteoarthritis Drugs Sales by Application (2020-2025) & (MT)
Table 39. APAC Osteoarthritis Drugs Sales by Region (2020-2025) & (MT)
Table 40. APAC Osteoarthritis Drugs Sales Market Share by Region (2020-2025)
Table 41. APAC Osteoarthritis Drugs Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Osteoarthritis Drugs Sales by Type (2020-2025) & (MT)
Table 43. APAC Osteoarthritis Drugs Sales by Application (2020-2025) & (MT)
Table 44. Europe Osteoarthritis Drugs Sales by Country (2020-2025) & (MT)
Table 45. Europe Osteoarthritis Drugs Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Osteoarthritis Drugs Sales by Type (2020-2025) & (MT)
Table 47. Europe Osteoarthritis Drugs Sales by Application (2020-2025) & (MT)
Table 48. Middle East & Africa Osteoarthritis Drugs Sales by Country (2020-2025) & (MT)
Table 49. Middle East & Africa Osteoarthritis Drugs Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Osteoarthritis Drugs Sales by Type (2020-2025) & (MT)
Table 51. Middle East & Africa Osteoarthritis Drugs Sales by Application (2020-2025) & (MT)
Table 52. Key Market Drivers & Growth Opportunities of Osteoarthritis Drugs
Table 53. Key Market Challenges & Risks of Osteoarthritis Drugs
Table 54. Key Industry Trends of Osteoarthritis Drugs
Table 55. Osteoarthritis Drugs Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Osteoarthritis Drugs Distributors List
Table 58. Osteoarthritis Drugs Customer List
Table 59. Global Osteoarthritis Drugs Sales Forecast by Region (2026-2031) & (MT)
Table 60. Global Osteoarthritis Drugs Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Osteoarthritis Drugs Sales Forecast by Country (2026-2031) & (MT)
Table 62. Americas Osteoarthritis Drugs Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Osteoarthritis Drugs Sales Forecast by Region (2026-2031) & (MT)
Table 64. APAC Osteoarthritis Drugs Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Osteoarthritis Drugs Sales Forecast by Country (2026-2031) & (MT)
Table 66. Europe Osteoarthritis Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Osteoarthritis Drugs Sales Forecast by Country (2026-2031) & (MT)
Table 68. Middle East & Africa Osteoarthritis Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Osteoarthritis Drugs Sales Forecast by Type (2026-2031) & (MT)
Table 70. Global Osteoarthritis Drugs Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Osteoarthritis Drugs Sales Forecast by Application (2026-2031) & (MT)
Table 72. Global Osteoarthritis Drugs Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Johnson & Johnson Basic Information, Osteoarthritis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 74. Johnson & Johnson Osteoarthritis Drugs Product Portfolios and Specifications
Table 75. Johnson & Johnson Osteoarthritis Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 76. Johnson & Johnson Main Business
Table 77. Johnson & Johnson Latest Developments
Table 78. Pfizer Basic Information, Osteoarthritis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. Pfizer Osteoarthritis Drugs Product Portfolios and Specifications
Table 80. Pfizer Osteoarthritis Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 81. Pfizer Main Business
Table 82. Pfizer Latest Developments
Table 83. Eli Lilly Basic Information, Osteoarthritis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. Eli Lilly Osteoarthritis Drugs Product Portfolios and Specifications
Table 85. Eli Lilly Osteoarthritis Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 86. Eli Lilly Main Business
Table 87. Eli Lilly Latest Developments
Table 88. Abbott Basic Information, Osteoarthritis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. Abbott Osteoarthritis Drugs Product Portfolios and Specifications
Table 90. Abbott Osteoarthritis Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 91. Abbott Main Business
Table 92. Abbott Latest Developments
Table 93. GlaxoSmithKline Basic Information, Osteoarthritis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. GlaxoSmithKline Osteoarthritis Drugs Product Portfolios and Specifications
Table 95. GlaxoSmithKline Osteoarthritis Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 96. GlaxoSmithKline Main Business
Table 97. GlaxoSmithKline Latest Developments
Table 98. Sanofi Basic Information, Osteoarthritis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Sanofi Osteoarthritis Drugs Product Portfolios and Specifications
Table 100. Sanofi Osteoarthritis Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 101. Sanofi Main Business
Table 102. Sanofi Latest Developments
Table 103. Flexion Therapeutics Basic Information, Osteoarthritis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Flexion Therapeutics Osteoarthritis Drugs Product Portfolios and Specifications
Table 105. Flexion Therapeutics Osteoarthritis Drugs Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 106. Flexion Therapeutics Main Business
Table 107. Flexion Therapeutics Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Osteoarthritis Drugs
Figure 2. Osteoarthritis Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Osteoarthritis Drugs Sales Growth Rate 2020-2031 (MT)
Figure 7. Global Osteoarthritis Drugs Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Osteoarthritis Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Osteoarthritis Drugs Sales Market Share by Country/Region (2024)
Figure 10. Osteoarthritis Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Oral
Figure 12. Product Picture of Injection
Figure 13. Product Picture of External
Figure 14. Global Osteoarthritis Drugs Sales Market Share by Type in 2025
Figure 15. Global Osteoarthritis Drugs Revenue Market Share by Type (2020-2025)
Figure 16. Osteoarthritis Drugs Consumed in Hospital Pharmacies
Figure 17. Global Osteoarthritis Drugs Market: Hospital Pharmacies (2020-2025) & (MT)
Figure 18. Osteoarthritis Drugs Consumed in Retail Pharmacies
Figure 19. Global Osteoarthritis Drugs Market: Retail Pharmacies (2020-2025) & (MT)
Figure 20. Osteoarthritis Drugs Consumed in Online Pharmacies
Figure 21. Global Osteoarthritis Drugs Market: Online Pharmacies (2020-2025) & (MT)
Figure 22. Global Osteoarthritis Drugs Sale Market Share by Application (2024)
Figure 23. Global Osteoarthritis Drugs Revenue Market Share by Application in 2025
Figure 24. Osteoarthritis Drugs Sales by Company in 2025 (MT)
Figure 25. Global Osteoarthritis Drugs Sales Market Share by Company in 2025
Figure 26. Osteoarthritis Drugs Revenue by Company in 2025 ($ millions)
Figure 27. Global Osteoarthritis Drugs Revenue Market Share by Company in 2025
Figure 28. Global Osteoarthritis Drugs Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Osteoarthritis Drugs Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Osteoarthritis Drugs Sales 2020-2025 (MT)
Figure 31. Americas Osteoarthritis Drugs Revenue 2020-2025 ($ millions)
Figure 32. APAC Osteoarthritis Drugs Sales 2020-2025 (MT)
Figure 33. APAC Osteoarthritis Drugs Revenue 2020-2025 ($ millions)
Figure 34. Europe Osteoarthritis Drugs Sales 2020-2025 (MT)
Figure 35. Europe Osteoarthritis Drugs Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Osteoarthritis Drugs Sales 2020-2025 (MT)
Figure 37. Middle East & Africa Osteoarthritis Drugs Revenue 2020-2025 ($ millions)
Figure 38. Americas Osteoarthritis Drugs Sales Market Share by Country in 2025
Figure 39. Americas Osteoarthritis Drugs Revenue Market Share by Country (2020-2025)
Figure 40. Americas Osteoarthritis Drugs Sales Market Share by Type (2020-2025)
Figure 41. Americas Osteoarthritis Drugs Sales Market Share by Application (2020-2025)
Figure 42. United States Osteoarthritis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Osteoarthritis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Osteoarthritis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Osteoarthritis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Osteoarthritis Drugs Sales Market Share by Region in 2025
Figure 47. APAC Osteoarthritis Drugs Revenue Market Share by Region (2020-2025)
Figure 48. APAC Osteoarthritis Drugs Sales Market Share by Type (2020-2025)
Figure 49. APAC Osteoarthritis Drugs Sales Market Share by Application (2020-2025)
Figure 50. China Osteoarthritis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Osteoarthritis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Osteoarthritis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Osteoarthritis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 54. India Osteoarthritis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Osteoarthritis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 56. China Taiwan Osteoarthritis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Osteoarthritis Drugs Sales Market Share by Country in 2025
Figure 58. Europe Osteoarthritis Drugs Revenue Market Share by Country (2020-2025)
Figure 59. Europe Osteoarthritis Drugs Sales Market Share by Type (2020-2025)
Figure 60. Europe Osteoarthritis Drugs Sales Market Share by Application (2020-2025)
Figure 61. Germany Osteoarthritis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 62. France Osteoarthritis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Osteoarthritis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Osteoarthritis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Osteoarthritis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Osteoarthritis Drugs Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Osteoarthritis Drugs Sales Market Share by Type (2020-2025)
Figure 68. Middle East & Africa Osteoarthritis Drugs Sales Market Share by Application (2020-2025)
Figure 69. Egypt Osteoarthritis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Osteoarthritis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Osteoarthritis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 72. Turkey Osteoarthritis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Osteoarthritis Drugs Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Osteoarthritis Drugs in 2025
Figure 75. Manufacturing Process Analysis of Osteoarthritis Drugs
Figure 76. Industry Chain Structure of Osteoarthritis Drugs
Figure 77. Channels of Distribution
Figure 78. Global Osteoarthritis Drugs Sales Market Forecast by Region (2026-2031)
Figure 79. Global Osteoarthritis Drugs Revenue Market Share Forecast by Region (2026-2031)
Figure 80. Global Osteoarthritis Drugs Sales Market Share Forecast by Type (2026-2031)
Figure 81. Global Osteoarthritis Drugs Revenue Market Share Forecast by Type (2026-2031)
Figure 82. Global Osteoarthritis Drugs Sales Market Share Forecast by Application (2026-2031)
Figure 83. Global Osteoarthritis Drugs Revenue Market Share Forecast by Application (2026-2031)